International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

Levofloxacin 50 mg/mL in SyrSpend SF pH4 Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2020 - Volume 24, Number 5
View All Articles in Issue

Page(s): 407

Levofloxacin 50 mg/mL in SyrSpend SF pH4 Oral Suspension Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Levofloxacin 50 mg/mL in SyrSpend SF pH4 Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: levofloxacin, fluoroquinolone anti-infective agent, antibiotic, formulation

Related Categories: FORMULATIONS, DOSAGE FORMS/DRUG CARRIERS, INFECTIOUS DISEASE

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Levofloxacin 50 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Sep/Oct 2020 Pg. 407
Levofloxacin 50-mg/mL in Ora-Plus and Strawberry Syrup Suspension Allen Loyd V Jr	May/Jun 2021 Pg. 232
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 55
Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions de Oliveira Ferreira Anderson, Polonini Hudson C, Loures da Silva Sharlene, Cerqueira de Melo Victor Augusto, de Andrade Laura, Fernandes Brandão Marcos Antônio	May/Jun 2017 Pg. 255-263
Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension Allen Loyd V Jr	Jul/Aug 2018 Pg. 320
Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 412
Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2020 Pg. 60
Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Mar/Apr 2022 Pg. 140
Sulfadiazine 100 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Nov/Dec 2021 Pg. 508
Pyridoxine Hydrochloride 50 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2022 Pg. 149
Acetaminophen (Paracetamol) 50 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jan/Feb 2021 Pg. 42
Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 47
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 503
Nitrofurantoin 2 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Mar/Apr 2020 Pg. 134
Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2019 Pg. 53
Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2017 Pg. 491
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 494
Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension Allen Loyd V Jr	Nov/Dec 2019 Pg. 486
Return to Top